Nanovibronix, Inc. (NASDAQ:FEED) Sees Large Growth in Short Interest

Nanovibronix, Inc. (NASDAQ:FEED) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 161,665 shares, a growth of 165.7% from the June 30th total of 60,839 shares. Approximately 2.7% of the company’s shares are short sold. Based on an average daily trading volume, of 507,400 shares, the days-to-cover ratio is presently 0.3 days.

Insider Activity at Nanovibronix

In other Nanovibronix news, insider Christian Michael Glibert sold 210,000 shares of the company’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $0.69, for a total value of $144,900.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 5.20% of the company’s stock.

Analyst Ratings Changes

FEED has been the subject of several analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of Nanovibronix in a report on Tuesday, July 21st. Wall Street Zen raised shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a research note on Sunday, July 12th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Nanovibronix presently has an average rating of “Sell”.

Nanovibronix Price Performance

Nanovibronix stock traded down $0.02 during trading hours on Monday, reaching $0.36. 100,481 shares of the company’s stock were exchanged, compared to its average volume of 5,933,434. The stock’s 50 day moving average price is $0.68. Nanovibronix has a twelve month low of $0.34 and a twelve month high of $17.40. The firm has a market cap of $2.18 million, a price-to-earnings ratio of -0.04 and a beta of 1.56.

Nanovibronix (NASDAQ:FEED) last announced its quarterly earnings data on Monday, May 18th. The company reported ($6.88) earnings per share (EPS) for the quarter. Nanovibronix had a negative net margin of 923.20% and a negative return on equity of 54.25%. The business had revenue of $0.65 million during the quarter.

About Nanovibronix

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.